BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16052427)

  • 1. Molecular epidemiology of non-small cell lung cancer.
    Liu G; Zhou W; Christiani DC
    Semin Respir Crit Care Med; 2005 Jun; 26(3):265-72. PubMed ID: 16052427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.
    Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland L; Phillips DH; Canzian F; Haugen A
    Carcinogenesis; 2006 Mar; 27(3):560-7. PubMed ID: 16195237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in TDG and MGMT genes - epidemiological and functional study in lung cancer patients from Poland.
    KrzeĊ›niak M; Butkiewicz D; Samojedny A; Chorazy M; Rusin M
    Ann Hum Genet; 2004 Jul; 68(Pt 4):300-12. PubMed ID: 15225156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis.
    Kiyohara C; Takayama K; Nakanishi Y
    Lung Cancer; 2006 Dec; 54(3):267-83. PubMed ID: 16982113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
    De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
    Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers.
    Gao WM; Romkes M; Siegfried JM; Luketich JD; Keohavong P
    Mol Carcinog; 2006 Nov; 45(11):828-32. PubMed ID: 16865671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XRCC1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Classen V; Bernges U; Philipp M
    Int J Mol Med; 2005 Oct; 16(4):709-16. PubMed ID: 16142409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular epidemiology of lung cancer.
    Schwartz AG; Prysak GM; Bock CH; Cote ML
    Carcinogenesis; 2007 Mar; 28(3):507-18. PubMed ID: 17183062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 1 receptor antagonist gene polymorphism and risk of lung cancer: a possible interaction with polymorphisms in the interleukin 1 beta gene.
    Lind H; Zienolddiny S; Ryberg D; Skaug V; Phillips DH; Haugen A
    Lung Cancer; 2005 Dec; 50(3):285-90. PubMed ID: 16126303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers.
    Ryk C; Kumar R; Thirumaran RK; Hou SM
    Lung Cancer; 2006 Dec; 54(3):285-92. PubMed ID: 17034901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
    Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
    Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Individual predisposition to lung neoplasm--the role of genes involved in metabolism of carcinogens].
    Butkiewicz D; Chorazy M
    Postepy Hig Med Dosw; 1999; 53(5):655-73. PubMed ID: 10645142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association between the XPD 312, 751, or XRCC1 399 polymorphisms and K-ras gene mutation in smoking non-small-cell lung cancer.
    Gao WM; Romkes M; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):673-5. PubMed ID: 15066937
    [No Abstract]   [Full Text] [Related]  

  • 14. Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
    Improta G; Sgambato A; Bianchino G; Zupa A; Grieco V; La Torre G; Traficante A; Cittadini A
    Anticancer Res; 2008; 28(5B):2941-6. PubMed ID: 19031937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers.
    Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland LB; Canzian F; Haugen A
    Carcinogenesis; 2008 Jun; 29(6):1164-9. PubMed ID: 18258609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer.
    Hao B; Miao X; Li Y; Zhang X; Sun T; Liang G; Zhao Y; Zhou Y; Wang H; Chen X; Zhang L; Tan W; Wei Q; Lin D; He F
    Oncogene; 2006 Jun; 25(25):3613-20. PubMed ID: 16652158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women.
    Yin J; Vogel U; Ma Y; Qi R; Wang H
    Cancer Genet Cytogenet; 2009 Jan; 188(1):26-31. PubMed ID: 19061777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
    Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
    Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
    Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
    Carcinogenesis; 2006 Mar; 27(3):525-32. PubMed ID: 16195240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer in never smokers: a review.
    Subramanian J; Govindan R
    J Clin Oncol; 2007 Feb; 25(5):561-70. PubMed ID: 17290066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.